← back to search

James W. Rocco

Massachusetts General Hospital · US
Area of research
Otorhinolaryngology · Oncology
Research interest
Research interests include Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, Cancer Diagnosis and Treatment, and Lung Cancer Treatments and Mutations.
h-index
52
citations
14,404
works
284
NIH funding
primary concept
Medicine
email

Recent publications

NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025
Journal of the National Comprehensive Cancer Network 2025cited by 118position: middledoi
Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline Update
Archives of Pathology & Laboratory Medicine 2025cited by 33position: middledoi
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
Cell Reports 2024cited by 67position: middledoi
Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma
Nature Genetics 2023cited by 106position: middledoi
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
Journal of the National Comprehensive Cancer Network 2022cited by 524position: middledoi
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma
Journal for ImmunoTherapy of Cancer 2022cited by 36position: middledoi
Head and neck cancer
The Lancet 2021cited by 799position: middledoi
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study
Cancers 2021cited by 57position: middledoi
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2020cited by 1,358position: middledoi
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
Journal of the National Comprehensive Cancer Network 2018cited by 626position: middledoi
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
Cell 2017cited by 2,589position: middledoi
Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists
Archives of Pathology & Laboratory Medicine 2017cited by 551position: middledoi
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
Journal of the National Comprehensive Cancer Network 2017cited by 377position: middledoi
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline
Practical Radiation Oncology 2017cited by 105position: middledoi
Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas
PLoS Medicine 2015cited by 298position: lastdoi
MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
Oral Oncology 2012cited by 448position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Nabil F. Saba · Emory University3 papers (2021–2022)William C. Faquin · Massachusetts Eye and Ear Infirmary3 papers (2017–2025)Edmund A. Mroz · The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute3 papers (2012–2017)Justin A. Bishop · Southwestern Medical Center2 papers (2017–2025) · 2 papers (2021–2022)Christina Lacchetti · Medical College of Wisconsin2 papers (2017–2025)Jameel Muzaffar · University of South Florida2 papers (2021–2022)Michael J. Schell · Moffitt Cancer Center2 papers (2021–2022)Raja R. Seethala · University of Pittsburgh2 papers (2017–2025) · 2 papers (2017–2025)Beth M. Beadle · Stanford University2 papers (2017–2025) · 2 papers (2021–2022)Conor Steuer · Emory Healthcare2 papers (2021–2022)Priyanka Bhateja · The Ohio State University2 papers (2021–2022)Jiannong Li · University of South Florida2 papers (2021–2022)Mary R. Schwartz · Houston Methodist2 papers (2017–2025)Joel T. Moncur · Office of the Director2 papers (2017–2025)Marcelo Bonomi · Wake Forest University2 papers (2021–2022)James S. Lewis · Rush University Medical Center2 papers (2017–2025)Christine H. Chung · Diabetes & Endocrine Associates2 papers (2021–2022)